Mon, April 13, 2020

Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $53 on, Apr 13th, 2020

Raghuram Selvaraju of HC Wainwright & Co., Maintained "UroGen Pharma Ltd." (URGN) at Strong Buy with Decreased Target from $75 to $53 on, Apr 13th, 2020.

Raghuram has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $45 on, Monday, April 6th, 2020


Similar Stocks and Investing Publications